Our Team

Our team of biopharmaceutical drug development leaders, industry professionals, strategic thinkers and transactional experts oversee a network of over 200 top-tier consultants whose experience and expertise span the essential drug development disciplines beginning in Late Discovery and encompassing Preclinical and Clinical Development, Commercialization/Launch and Life-Cycle Management.

Biopharmaceutical Drug Development

Carol Bye, BE,
FIChemE,

Quality & Compliance

Michael Placke, PhD, DABT - Nonclinical Sciences


Michael Placke, PhD, DABT

Nonclinical Sciences